Google DeepMind co-founder & CEO Demis Hassabis speaks with columnist Bina Venkataraman about AI’s role in enabling scientific breakthroughs, why human-level intelligence is an “important ...

"There's no real point in having regulation only in one region of the world, because AI sort of is across borders; it's going ...

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

This year’s Nobel Prizes were a “watershed moment” for artificial intelligence, according to Demis Hassabis, a co-winner of this year’s prize in chemistry. Hassabis, 48, CEO and co-founder ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its parent company, Alphabet. The start-up’s potential has attracted big ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...

The biggest figures in artificial intelligence sparred over the dangers of the rapidly advancing technology at the World ...